Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Meiying Chang"'
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e21050- (2023)
Ferroptosis is found to be involved in some experimental models of kidney diseases, but its role in membrane nephropathy (MN) is still unclear. The purpose of this study is to explore whether ferroptosis occurred in MN, and the role of ferritinophagy
Externí odkaz:
https://doaj.org/article/4f7cafd67f73453992c2d55da4fb5953
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 163, Iss , Pp 114849- (2023)
Acute kidney injury (AKI) is a major health concern owing to its high morbidity and mortality rates, to which there are no drugs or treatment methods, except for renal replacement therapy. Therefore, identifying novel therapeutic targets and drugs fo
Externí odkaz:
https://doaj.org/article/170c6985138b45508d11d407f6fe9cde
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 156, Iss , Pp 113916- (2022)
Glomerular diseases are major components of kidney disease, mainly manifested as podocyte disease, immune complex-associated glomerulonephritis, and renal autoimmune disease. They are the third leading cause of end-stage renal disease, especially in
Externí odkaz:
https://doaj.org/article/b469ac9ef1ef4ebda4ac394c74f0d59b
Autor:
Mingming Zhao, Ziyan Zhang, Zhiyu Pan, Sijia Ma, Meiying Chang, Jiao Fan, Shunxuan Xue, Yuejun Wang, Hua Qu, Yu Zhang
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 338 (2023)
Renin-angiotensin system (RAS) inhibitors and calcium channel blockers (CCB) are often used together in chronic kidney disease (CKD). The PubMed, EMBASE, and Cochrane Library databases were searched to identify randomized controlled trials (RCTs) in
Externí odkaz:
https://doaj.org/article/69b79243094d48dfa210d7cb2ce46e5b
Autor:
Meiying Chang, Bin Yang, Liusheng Li, Yuan Si, Mingming Zhao, Wei Hao, Jinning Zhao, Yu Zhang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Modified Huangqi Chifeng decoction (MHCD) has been used to reduce proteinuria in immunoglobulin A nephropathy (IgAN) for many years. Previously, we have demonstrated its protective role in glomerular mesangial cells. Podocyte injury, another key fact
Externí odkaz:
https://doaj.org/article/dfbcce5ead954a3c906e0d3fec8ee34e
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: The purpose of this meta-analysis was to evaluate the controversy of angiotensin-converting enzyme inhibitor (ACEI) in combination with angiotensin-receptor blocker (ARB) in the treatment of chronic kidney disease (CKD) based on dose.Meth
Externí odkaz:
https://doaj.org/article/f62ab1483c61459bb0e5673962bbd2f5
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2021)
As the current treatment of chronic kidney disease (CKD) is limited, it is necessary to seek more effective and safer treatment methods, such as Chinese herbal medicines (CHMs). In order to clarify the modern theoretical basis and molecular mechanism
Externí odkaz:
https://doaj.org/article/ccf60449e37a45949ad01e51ada95ecd
Publikováno v:
Medicine; 3/10/2023, Vol. 102 Issue 10, p1-9, 9p
Autor:
Qi Li, zhiyu Pan, jiao Fan, Sijia Ma, Yu Zhang, Mingming Zhao, Ziyan Zhang, Shunxuan Xue, Meiying Chang
Publikováno v:
International Journal of General Medicine
Sijia Ma,1 Mingming Zhao,1 Jiao Fan,1 Meiying Chang,1 Zhiyu Pan,1 Ziyan Zhang,1 Shunxuan Xue,1 Qi Li,2 Yu Zhang1 1Department of Nephrology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, Peopleâs Republic of China; 2Departm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a832d0a3a92c035959e72ed90891475
https://doi.org/10.2147/ijgm.s323511
https://doi.org/10.2147/ijgm.s323511
Autor:
Qiuyi Li, Meiying Chang, Runmin Lai, He Zhang, Luxia Song, Xinyi Wang, Baoyi Guan, Jie Zhang, Lin Zhao, Keji Chen, Anlu Wang, Hao Xu
Publikováno v:
Nutrition. 112:112062
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99b7d1bd7654414db528e6c9b0687b61
https://doi.org/10.1016/j.nut.2023.112062
https://doi.org/10.1016/j.nut.2023.112062